Journal of Inherited Metabolic Disease

, Volume 29, Issue 1, pp 58–63 | Cite as

Effect of docosahexaenoic acid administration on plasma lipid profile and metabolic parameters of children with methylmalonic acidaemia

  • L. Aldámiz-Echevarría
  • P. Sanjurjo
  • J. Elorz
  • J. A. Prieto
  • C. Pérez
  • F. Andrade
  • J. Rodríguez-Soriano
Original Article

Summary

Aim. To evaluate the effect of administration of docosahexaenoic acid (DHA) on dyslipidaemia, plasma fatty acid composition and metabolic parameters of children with isolated methylmalonic acidaemia (MMA) (McKusick 25100).

Methods. Four children (3 male, 1 female) with MMA (mut(0)), participated in a crossover, randomized study of DHA administration (25 mg/kg per day, divided into three daily doses). The control group comprised 56 healthy children, aged 10± 2.7 years, (51 male, 5 female), who were followed in our clinic owing to possible familial risk of cardiovascular disease.

Results. The comparison of plasma fatty acid composition of children with MMA versus control children demonstrated that the patients had significantly higher values for oleic acid (p = 0.004) and linolenic acid (p = 0.008). No differences were observed in the levels of DHA and arachidonic acid. Plasma concentrations of insulin, glycine, ammonia, total cholesterol and cholesterol fractions did not change with DHA administration. No significant changes were observed in urinary excretion of methylmalonic acid. As expected, the percentage of DHA and n−3 fatty acids in plasma increased significantly after therapy (p = 0.005 and 0.014, respectively). The most remarkable result was a decrease of plasma levels of triglycerides after DHA therapy (p = 0.014).

Conclusion. As previously found in normal children, dietary supplementation with DHA decreases the triglyceride levels, normalizing the hypertriglyceridaemia of these children without any evidence of short-term adverse effects.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baumgarter ER, Viardot C (1995) Long-term follow-up of 77 patients with isolated methymalonic acidemia. J Inherit Metab Dis 18: 138–142.CrossRefPubMedGoogle Scholar
  2. Chan DC, Watts GF, Mori TA, et al (2003) Randomized controlled trial of the effect of n − 3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity. Am J Clin Nutr 77: 300–307.PubMedGoogle Scholar
  3. Clarke SD (2004) The multidimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors. Curr Opin Lipidol 15: 13–18.PubMedGoogle Scholar
  4. Coker M, de Klerk JB, Poll-The BT, Huijmans JG, Duran M (1996) Plasma total odd-chain fatty acids in the monitoring of disorders of propionate, methylmalonate and biotin metabolism. J Inherit Metab Dis 19: 743–751.PubMedGoogle Scholar
  5. D’Ángio CT, Dillon MJ, Leonard JV (1991) Renal tubular dysfunction in tubulointersticial nephritis in methyl-malonic acidemia. Eur J Pediatr 150: 259–263.PubMedGoogle Scholar
  6. Das UN (2004) Long-chain polyunsaturated fatty acids interact with nitric oxide, superoxide anion, and transforming growth factor-beta to prevent human essential hypertension. Eur J Clin Nutr 58: 195–203.CrossRefPubMedGoogle Scholar
  7. Decsi T, Sperl W, Koletzko B (1997) Essential fatty acids in clinically stable children with propionic acidaemia. J Inherit Metab Dis 20: 778–782.CrossRefPubMedGoogle Scholar
  8. Fisher WR, Zech LA, Stacpoole PW (1998) Apolipoprotein B metabolism in hypertriglyceridemic diabetic patients administered either a fish oil or vegetable oil-enriched diet. J Lipid Res 39: 388–401.PubMedGoogle Scholar
  9. Friedewald WT, Levy IR, Fredrickson DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the separative ultracentrifuge. Clin Chem 18: 499–502.PubMedGoogle Scholar
  10. Giovannini M, Biasucci G, Agostoni C, Luotti D, Riva E (1995) Lipid status and fatty acid metabolism in PKU. J Inherit Metab Dis 18: 265–272.CrossRefPubMedGoogle Scholar
  11. Glasgow AM, Chase HP (1976) Effect of propionic acid on fatty acid oxidation and ureagenesis. Pediatr Res 10: 683–686.PubMedGoogle Scholar
  12. Grimble RF, Howell WM, O’Reilly G, et al (2002) The ability of fish oil to suppress tumor necrosis factor alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor alpha production. Am J Clin Nutr 76: 454–459.PubMedGoogle Scholar
  13. Guyatt GH, Keller JL, Jaexchke R, et al (1990) The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience. Ann Intern Med 112: 293–299.PubMedGoogle Scholar
  14. Hamar P, Muller V, Kohnle M, et al (1997) Metabolic factors have a major impact on kidney allograft survival. Transplantation 64: 1135–1139.PubMedGoogle Scholar
  15. Kolker S, Schwab M, Horster F, et al (2003) Methylmalonic acid, a biochemical hallmark of methylmalonic acidurias but no inhibitor of mitocondrial respiratory chain. J Biol Chem 28: 47388–47393.Google Scholar
  16. Leonard JV (1995) The management and outcome of propionic and methyl-malonic acidaemia. J Inherit Metab Dis 18: 430–434.CrossRefPubMedGoogle Scholar
  17. Lepage G, Roy CC (1986) Direct transesterification of all classes of lipids in one step reaction. J Lipid Res 27: 114–120.PubMedGoogle Scholar
  18. Li H, Ruan XZ, Powis SH, et al (2005) EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent-mechanism. Kidney Int 67: 867–874.PubMedGoogle Scholar
  19. Lopes-Virella MF, Stone P, Ellis S, Colwell JA (1977) Cholesterol determination in high density lipoproteins separated by three different methods. Clin Chem 23: 882–884.PubMedGoogle Scholar
  20. Marcovina SM, Albers JJ, Kennedy H, Mei JV, Henderson LO, Hannon WH (1994) International Federation of Clinical Chemistry standarization project for measurements of apolipoproteins AI and B (IV). Comparability of apolipoprotein B values by use of international reference material. Clin Chem 40: 586–592.PubMedGoogle Scholar
  21. McCowen KC, Bistrian BR (2005) Esential fatty acids and their derivates. Curr Opin Gastroenterol 21: 207–215.CrossRefPubMedGoogle Scholar
  22. Mishra A, Chaudhary A, Sethi S (2004) Oxidized omega-3 fatty acids inhibit NF-kappaB activation via a PPARalpha-dependent pathway. Arterioscler Thromb Vasc Biol 24: 1621–1627.PubMedGoogle Scholar
  23. Molteni KH, Oberley TD, Wolff JA, Friedman AL (1991) Progressive renal insufficiency in methylmalonic acidemia. Pediatr Nephrol 5: 323–326.CrossRefPubMedGoogle Scholar
  24. Nestel PJ, Connor WE, Reardon MF, Connor S, Wong S, Boston R (1984) Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest 74: 82–89.PubMedGoogle Scholar
  25. Okun JG, Horster F, Farkas LM, et al (2002) Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic acid cycle, and synergistically acting excitotoxicity. Biol Chem 26(277): 14674–14680.Google Scholar
  26. Park Y, Harris WS (2003) Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearence. J Lipid Res 44: 455–463.PubMedGoogle Scholar
  27. Price PT, Nelson CM, Clarke SD (2000) Omega-3 polyunsaturated fatty acid regulation of gene expression. Curr Opin Lipidol 11: 3–7.CrossRefPubMedGoogle Scholar
  28. Richardson AJ, Montgomery P (2005) The Oxford-Durham study: A randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics 115: 1360–1366.CrossRefPubMedGoogle Scholar
  29. Rottoli A, Lista G, Zecchini G, Butte C, Longhi R (1985) Plama selenium levels in treated phenylketonuric patients. J Inherit Metab Dis 18(Supplement 2): 127–128.Google Scholar
  30. Sanjurjo P (2001) Acidemias metil-malónica y propiónica. In: Sanjurjo P, Baldellou A, eds. Diagnóstico y Tratamiento de las enfermedades metabólicas hereditaríal. Madrid: Ergon, 247–255.Google Scholar
  31. Sanjurjo P, Perteagudo L, Rodriguez Soriano J, Vilaseca A, Campistol J (1994) Polyunsaturated fatty acids status in patients with phenylketonuria. J Inherit Metab Dis 17: 704–709.CrossRefPubMedGoogle Scholar
  32. Sanjurjo P, Ruiz J, Montejo M (1997) Inborn errors of metabolism with a protein restricted diet: effect on polyunsaturated fatty acids. J Inherit Metab Dis 20: 783–789.CrossRefPubMedGoogle Scholar
  33. Schulpis KH, Nounopoulus C, Scarpalezou A, Bouloukos A, Missiou-Tsagarakis S (1990) Serum carnitine level in phenylketonuric children under dietary control in Greece. Acta Pediatr Scand 79: 930–934.Google Scholar
  34. Shimizu N, Yamaguchi S, Orii T (1994) A study of urinary metabolites in patients with dicarboxylic aciduria for differential diagnosis. Acta Paediatr Jpn 36: 139–145.PubMedGoogle Scholar
  35. Silverstein DM, Palmer J, Polinsky MS, Braas C, Conley SB, Baluarte HJ (2000) Risk factors for hyperlipidemia in long-term pediatric renal transplant recipients. Pediatr Nephrol 14: 105–110.CrossRefPubMedGoogle Scholar
  36. Ten S, Maclaren N (2004) Insulin resistance syndrome in children. J Clin Endocrinol Metab 89: 2526–2539.CrossRefPubMedGoogle Scholar
  37. Van Calcar SC, Harding CO, Lyne P, et al (1998) Renal transplantation in a patient with methylmalonic acidaemia. J Inherit Metab Dis 21: 729–737.CrossRefPubMedGoogle Scholar
  38. Van Hoff WG, Dixon M, Taylor J, et al (1998) Combined liver–kidney transplantation in methylmalonic acidemia. J Pediatr 132: 1043–1044.Google Scholar
  39. Wahlefeld AW (1974) Triglycerides, determination after enzymatic hydrolysis. In: Bermeyer HU, eds. Methods of Enzymatic Analysis, 2nd edn. New York: Academic Press, 1831–1835.Google Scholar
  40. Wallace FA, Miles EA, Calder PC (2003) Comparison of the effects of linseed oil and different doses of fish oil on mononuclear cell function in healthy human subjects. Br J Nutr 89: 679–689.CrossRefPubMedGoogle Scholar
  41. Weber P, Raederstorff D (2000) Triglyceride lowering effect of omega 3 LC polyunsaturated fatty acids. Nutr Metab Cardiovasc Dis 10: 28–37.PubMedGoogle Scholar
  42. Westphal S, Orth M, Ambrosch A, Osmundsen K, Luley C (2000) Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n − 3 fatty acids. Am J Clin Nutr 71: 914–920.PubMedGoogle Scholar
  43. Yamamoto K, Itoh T, Abe D, et al (2005) Identification of putative metabolites of docosahexaenoic acid as potent PPARgamma agonists and antidiabetic agents. Bioorg Med Chem Lett 15: 517–522.PubMedGoogle Scholar

Copyright information

© SSIEM and Springer 2006

Authors and Affiliations

  • L. Aldámiz-Echevarría
    • 1
    • 2
  • P. Sanjurjo
    • 2
  • J. Elorz
    • 2
  • J. A. Prieto
    • 2
  • C. Pérez
    • 2
  • F. Andrade
    • 2
  • J. Rodríguez-Soriano
    • 2
  1. 1.Departamento de PediatríaHospital de CrucesBaracaldoSpain
  2. 2.Division of Metabolism, Department of PediatricsHospital de Cruces and Basque University School of MedicineBilbaoSpain

Personalised recommendations